CIK: 1489533 - Address: C/O Kala Bio, Inc., 1167 Massachusetts Avenue, Arlington, MA 02476
26 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret112010-1-3-1-25-5
S%wins55506053637960

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/24/20 16:25
8/20/20
ALIMAlimera Sciences IncHealthDrugPharmaceutical PreparationsMyers C. DanielGADS-346.730-5-476D
1/19/18 16:40
1/18/18
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOCEOS.m-631.200-53-4175D
1/18/18 16:53
1/16/18
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOCEOS.m-651.230-53-29128D
3/13/17 16:56
3/10/17
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOCEOS-291.391-21-10181D-73-20-723191678-3-4-10
10/13/16 16:14
10/11/16
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOCEOM.d731.3305513496D-71-46-2818-5-11-3-1-3-8-19-13-3
11/16/15 16:15
5/1/15
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS.a-94.371-2-289D70-38-28-195362-10-1-30-26-52-63
5/4/15 16:30
5/1/15
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-94.371-2-289D49-25-28-19-14-10-10-407-212-28-46
4/3/15 16:31
4/1/15
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-104.921-2-290D55-41-8-16-13-7-81-43-52-53-57
3/3/15 16:40
3/2/15
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-105.211-2-292D73-23-17-14-830-21-3-3-21-33-59
2/4/15 16:31
2/2/15
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-115.431-2-296D119-15-3-10-12-9-7-710-4-16-6-55
1/6/15 18:10
1/2/15
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-115.511-2-2103D22821-414544422-7-20-17-50
12/2/14 16:30
12/1/14
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGAOP,CEOS-125.991-2-2105D1411224-111593-3330-6-20-44
11/5/14 16:31
11/3/14
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-115.352-2-2107D100155-12-1062-17-1768186-7-33
10/2/14 18:40
10/1/14
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-115.423-2-2108D9321-35-15-11-1812-2-1178-10-61
9/4/14 16:30
9/2/14
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-126.191-2-2110D17773-112191014200-16-10-20-47
6/10/14 16:30
6/6/14
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-285.561-5-4111D9224150-15-85-6626464-21
3/5/14 17:51
3/4/14
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOM.d462.0422324116D8611796178-8311-2-810-25-12-27
3/5/14 17:51
3/4/14
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS.d-1627.102-23-16116D8611796178-8311-2-810-25-12-27
12/5/12 16:43
12/3/12
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-151.950-8-6118D-8452-35-22-31-18-10-190-15-46813931
11/5/12 17:22
11/1/12
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-152.520-6-5125D-78-66-9-71-8-3-2-2-3-21025-17
10/3/12 16:49
10/1/12
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-152.520-6-4139D-76-65-26-18940-5020-341852
9/5/12 17:13
9/4/12
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-152.360-6-4145D-74-66-45-19-21941547-273658
8/14/12 19:02
8/13/12
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-152.220-7-4151D-69-6832-17-28-26-19-10251271047
3/16/11 17:20
3/15/11
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS-3217.061-46-23149D-21-29-28-8-5-1-118108-43
3/14/11 17:26
3/10/11
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOM.d731.3315539195D-22-30-24-15-6-64-21170-40
3/14/11 17:26
3/10/11
ALIMAlimera Sciences IncDEHealthDrugPharmaceutical PreparationsMyers C. DanielGADOP,CEOS.d-747.661-10-5195D-22-30-24-15-6-64-21170-40

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact